Sezary syndrome treated with bexarotene: a case report

Autor:	L. Darrieux, G. Safa, O. Pennors-Quere
Rok vydání:	2009
Předmět:	Oncology Bexarotene medicine.medical_specialty Poor prognosis business.industry medicine.disease Subclass Lymphoma Endocrinology Internal medicine Medicine business medicine.drug
Zdroj:	Oncologie. 12:132-134
ISSN:	1765-2839 1292-3818
DOI:	10.1007/s10269-009-1115-4
Popis:	Sezary syndrome, the leukemic variant of cutaneous T-cell lymphoma, carries a poor prognosis. Treating Sezary syndrome is always a challenge. We report the case of a patient with Sezary syndrome who was successfully treated with bexarotene, a novel subclass of retinoids. However, bexarotene treatment is associated with unavoidable side effects that must be known and anticipated
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::028f8c9e7058ce728983fcb33e8c3f9f https://doi.org/10.1007/s10269-009-1115-4 Zobrazit plný text záznamu Full text from SpringerLink